Progression-free survival (PFS) with maintenance treatment with bevacizumab (B) in patients with responding mCRC after first-line chemotherapy (CT) plus B.
Maria Agnese Fabbri
No relevant relationships to disclose
Maria Fabbri
Disclosure not yet available
Fabrizio Nelli
No relevant relationships to disclose
Luca Moscetti
No relevant relationships to disclose
Enrico Cortesi
No relevant relationships to disclose
Teresa Gamucci
No relevant relationships to disclose
Isabella Sperduti
No relevant relationships to disclose
Daniela Franco
No relevant relationships to disclose
Ida Pavese
No relevant relationships to disclose
Roberta Grande
No relevant relationships to disclose
Daniele Alesini
No relevant relationships to disclose
Enzo Ruggeri
No relevant relationships to disclose